Early Access — free while we kick the tires
EdgarHawk

Ryan Preblick

Chief Financial Officer

Officer

Latest: Indivior Pharmaceuticals, Inc. CFO selling · June 2026

1 filing analyzed · 1 company · Latest 2026-06-10

Never miss a filing from Ryan Preblick

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Indivior Pharmaceuticals, Inc. INDV 0 1 Net selling

Activity

June 2026
2026-06-10 Indivior Pharmaceuticals, Inc. INDV 10b5-1 Plan
low
Sell
36,000 shares
$1,357,200
Significance 3/10

CFO Ryan Preblick sold 36,000 INDV shares at $37.70 via pre-arranged 10b5-1 plan; retains 284,751 shares

This sale of 36,000 shares (36.0K shares) for $1,357,200.00 ($1.4M) was executed under a 10b5-1 trading plan adopted on 2026-03-06, making it a scheduled transaction rather than a discretionary choice by Preblick. The CFO retains 284,751 shares (284.8K shares) post-transaction, representing a -11.2% reduction in his holdings. With current stock price at $38.26, the transaction occurred at $37.70, near recent trading levels, and the company maintains solid operational performance with $317,000,000.00 ($317.0M) in latest-quarter revenue and a P/E of 18.48.

Related insiders